Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
The Journal of Rheumatology
|
May 17, 2012
CCL18 -- potential biomarker of fibroinflammatory activity in chronic periaortitis
Florian Kollert, Moritz Binder, Corina Probst, et al.
The Journal of Experimental Medicine
|
April 12, 2003
Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen
Stephanie Kruetzmann, M Manuela Rosado, Holger Weber, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 20, 2006
ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells
Lukas Bossaller, Jan Burger, Ruth Draeger, et al.
Frontiers in Immunology
|
January 8, 2015
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe
Jacqueline Kerr, Isabella Quinti, Martha Eibl, et al.
Autoimmunity
|
June 8, 2013
B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides
Jens Thiel, Ulrich Salzer, Fabian Hässler, et al.
The Journal of Allergy and Clinical Immunology
|
September 21, 2011
Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency
Marta Rizzi, Carla Neumann, Adele K Fielding, et al.
Plos One
|
June 4, 2010
Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome
Marta Rizzi, Rolf Knoth, Christiane S Hampe, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 12, 2009
B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans
Klaus Warnatz, Ulrich Salzer, Marta Rizzi, et al.
BMC Musculoskeletal Disorders
|
August 1, 2015
Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study
Hubert G Nüßlein, Rieke Alten, Mauro Galeazzi, et al.
RMD Open
|
March 1, 2016
Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study
Rieke Alten, Hubert Nüßlein, Mauro Galeazzi, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
The Journal of Rheumatology
|
May 17, 2012
CCL18 -- potential biomarker of fibroinflammatory activity in chronic periaortitis
Florian Kollert, Moritz Binder, Corina Probst, et al.
The Journal of Experimental Medicine
|
April 12, 2003
Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen
Stephanie Kruetzmann, M Manuela Rosado, Holger Weber, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 20, 2006
ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells
Lukas Bossaller, Jan Burger, Ruth Draeger, et al.
Frontiers in Immunology
|
January 8, 2015
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe
Jacqueline Kerr, Isabella Quinti, Martha Eibl, et al.
Autoimmunity
|
June 8, 2013
B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides
Jens Thiel, Ulrich Salzer, Fabian Hässler, et al.
The Journal of Allergy and Clinical Immunology
|
September 21, 2011
Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency
Marta Rizzi, Carla Neumann, Adele K Fielding, et al.
Plos One
|
June 4, 2010
Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome
Marta Rizzi, Rolf Knoth, Christiane S Hampe, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 12, 2009
B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans
Klaus Warnatz, Ulrich Salzer, Marta Rizzi, et al.
BMC Musculoskeletal Disorders
|
August 1, 2015
Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study
Hubert G Nüßlein, Rieke Alten, Mauro Galeazzi, et al.
RMD Open
|
March 1, 2016
Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study
Rieke Alten, Hubert Nüßlein, Mauro Galeazzi, et al.
Page
of 6